首页 > 最新文献

Therapeutics and Clinical Risk Management最新文献

英文 中文
Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation. 房颤类型和慢性肾脏疾病是射频消融后房颤复发的独立预测因素。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-12-03 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S492265
Pei Mo, Cheng Fan, Jiayuan Chen, Yu Wang, Wenhao Xiao, Zhiguo Peng, Xiao-Zhen Lin, Cheng-Feng Luo, Chongyu Zhang

Purpose: Atrial fibrillation (AF) is classified into paroxysmal, persistent, long-term persistent, and permanent types. It is commonly treated by radiofrequency ablation (RFA), which is more successful than conventional anti-arrhythmic drugs, but it is still largely unknown whether these beneficial effects are equally present for all AF types. Here, we evaluated the impact that AF type has on post-RFA patient conditions and identified underlying factors affecting AF prognoses.

Patients and methods: Three hundred and twenty-nine AF patients who underwent RFA were retrospectively examined (221 paroxysmal, 56 persistent, 52 long-term persistent), during a post-RFA follow-up period, from 3-months to 2-years. Cardiac functional parameters, such as left atrial (LA), ventricular (LV), and pulmonary artery diameters, as well as ejection fraction (EF) and end-diastolic/systolic diameter ratio, were measured using echocardiography. Additionally, chronic kidney disease (CKD) was diagnosed among these AF patients, using the Modification of Diet in Renal Disease (MDRD) formula, and its impact on post-RFA patient outcomes was examined. Logistic regression analysis identified differences between AF and non-AF recurrence groups.

Results: In terms of functional parameters, persistent AF had significantly smaller LA, and larger EF, compared to paroxysmal and long-term persistent groups, while paroxysmal had significantly larger LV versus persistent and long-term persistent after RFA. For post-RFA patient conditions, paroxysmal, compared to persistent and long-term persistent, had significantly lower AF recurrence (18.10% versus 30.36% and 36.54%) and re-hospitalization rates (6.79% versus 14.29% and 19.23%); however, no significant difference was present between the 3 groups in terms of post-operative stroke rates, as well as re-hospitalization duration. Additionally, CKD patients, versus non-CKD, were more prone to AF recurrence and re-hospitalization, being 3.268 times more likely.

Conclusion: AF types and CKD were independent factors influencing AF recurrence, serving as highly sensitive predictors to monitor prognoses and guide treatments. Therefore, personalized treatment regimens should be recommended for different AF patients.

目的:心房颤动(AF)分为阵发性、持续性、长期持续性和永久性。通常采用射频消融术(RFA)治疗,这比传统的抗心律失常药物更成功,但这些有益效果是否对所有类型的房颤都同样存在,这在很大程度上仍然未知。在这里,我们评估了房颤类型对rfa后患者病情的影响,并确定了影响房颤预后的潜在因素。患者和方法:在RFA后3个月至2年的随访期间,回顾性检查了329例接受RFA治疗的AF患者(221例发作性,56例持续性,52例长期持续性)。使用超声心动图测量心脏功能参数,如左心房(LA)、心室(LV)和肺动脉直径,以及射血分数(EF)和舒张末期/收缩内径比。此外,在这些房颤患者中诊断慢性肾脏疾病(CKD),使用肾脏疾病饮食调整(MDRD)配方,并检查其对rfa后患者预后的影响。Logistic回归分析确定了房颤和非房颤复发组之间的差异。结果:在功能参数方面,与阵发性和长期持续性组相比,持续性房颤的LA明显更小,EF更大,而RFA后阵发性房颤的LV明显大于持续性和长期持续性房颤。对于rfa后患者情况,阵发性与持续性和长期持续性相比,AF复发率(18.10%比30.36%和36.54%)和再住院率(6.79%比14.29%和19.23%)显著降低;然而,在术后卒中发生率和再次住院时间方面,三组间无显著差异。此外,CKD患者比非CKD患者更容易发生房颤复发和再次住院,其可能性是非CKD患者的3.268倍。结论:房颤分型和CKD是影响房颤复发的独立因素,是监测预后和指导治疗的高度敏感的预测因素。因此,应针对不同的房颤患者推荐个性化的治疗方案。
{"title":"Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation.","authors":"Pei Mo, Cheng Fan, Jiayuan Chen, Yu Wang, Wenhao Xiao, Zhiguo Peng, Xiao-Zhen Lin, Cheng-Feng Luo, Chongyu Zhang","doi":"10.2147/TCRM.S492265","DOIUrl":"10.2147/TCRM.S492265","url":null,"abstract":"<p><strong>Purpose: </strong>Atrial fibrillation (AF) is classified into paroxysmal, persistent, long-term persistent, and permanent types. It is commonly treated by radiofrequency ablation (RFA), which is more successful than conventional anti-arrhythmic drugs, but it is still largely unknown whether these beneficial effects are equally present for all AF types. Here, we evaluated the impact that AF type has on post-RFA patient conditions and identified underlying factors affecting AF prognoses.</p><p><strong>Patients and methods: </strong>Three hundred and twenty-nine AF patients who underwent RFA were retrospectively examined (221 paroxysmal, 56 persistent, 52 long-term persistent), during a post-RFA follow-up period, from 3-months to 2-years. Cardiac functional parameters, such as left atrial (LA), ventricular (LV), and pulmonary artery diameters, as well as ejection fraction (EF) and end-diastolic/systolic diameter ratio, were measured using echocardiography. Additionally, chronic kidney disease (CKD) was diagnosed among these AF patients, using the Modification of Diet in Renal Disease (MDRD) formula, and its impact on post-RFA patient outcomes was examined. Logistic regression analysis identified differences between AF and non-AF recurrence groups.</p><p><strong>Results: </strong>In terms of functional parameters, persistent AF had significantly smaller LA, and larger EF, compared to paroxysmal and long-term persistent groups, while paroxysmal had significantly larger LV versus persistent and long-term persistent after RFA. For post-RFA patient conditions, paroxysmal, compared to persistent and long-term persistent, had significantly lower AF recurrence (18.10% versus 30.36% and 36.54%) and re-hospitalization rates (6.79% versus 14.29% and 19.23%); however, no significant difference was present between the 3 groups in terms of post-operative stroke rates, as well as re-hospitalization duration. Additionally, CKD patients, versus non-CKD, were more prone to AF recurrence and re-hospitalization, being 3.268 times more likely.</p><p><strong>Conclusion: </strong>AF types and CKD were independent factors influencing AF recurrence, serving as highly sensitive predictors to monitor prognoses and guide treatments. Therefore, personalized treatment regimens should be recommended for different AF patients.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"817-828"},"PeriodicalIF":2.8,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11624671/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women? 高强度聚焦电磁能治疗女性尿失禁有效吗?
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-11-30 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S478919
Halil Tosun, Emre Can Akınsal, Gökhan Sönmez, Numan Baydilli, Deniz Demirci

Purpose: To assess the effectiveness and safety of high-intensity focused electromagnetic technology (HIFEM) used as a therapeutic approach in patients with stress and mixed urinary incontinence.

Patients and methods: Thirty-five females suffering from stress and mixed urinary incontinence were included in the study. The electromagnetic chair (BTL EMSELLA®) was applied to the patient's pelvic area twice a week for 28 minutes, totaling 6 sessions. The patients' "International Consultation on Incontinence Questionnaire-Short Form" (ICIQ-SF) scores and the number of daily absorbent pad usage were recorded. Results were evaluated after the sixth session and at a first-month follow-up.

Results: The average ICIQ-SF score at baseline was 10.18 ± 4.19 (ranging from 2-18) which declined to 5.33 ± 3.97 after six sessions, and further improved to 4.26 ± 3.94 points at the one-month follow-up. After six sessions, an average improvement of 52.06% in ICIQ-SF score was observed, and after one month of follow-up, an average improvement of 59.6% was detected, which was found to be statistically significant (p=0.038). In addition, the mean number of pads used per day decreased to 1.25 ± 1.54 after treatment, a significant improvement was observed, and the mean daily pad use decreased further to 0.91 ± 1.11 at the first-month follow-up.

Conclusion: HIFEM has demonstrated in our study its ability to safely and effectively treat female patients suffering from stress and mixed urinary incontinence, as evidenced by significant improvements in symptoms and quality of life observed in clinical trials.

目的:评价高强度聚焦电磁技术(HIFEM)治疗应激性混合性尿失禁的有效性和安全性。患者与方法:选取35例女性压力性混合性尿失禁患者作为研究对象。电磁椅(BTL EMSELLA®)应用于患者骨盆区域,每周2次,每次28分钟,共6次。记录患者“国际尿失禁咨询问卷-短表”(ICIQ-SF)评分及每日使用吸水垫次数。在第六次治疗后和第一个月随访时对结果进行评估。结果:基线时ICIQ-SF平均评分为10.18±4.19分(2 ~ 18分),6次随访后降至5.33±3.97分,1个月随访时进一步提高至4.26±3.94分。6个疗程后ICIQ-SF评分平均改善52.06%,随访1个月后平均改善59.6%,差异有统计学意义(p=0.038)。此外,治疗后平均每天使用的尿垫数减少到1.25±1.54个,显著改善,在第一个月的随访中,平均每天使用的尿垫数进一步减少到0.91±1.11个。结论:在我们的研究中,HIFEM已经证明了它能够安全有效地治疗患有压力和混合性尿失禁的女性患者,临床试验中观察到的症状和生活质量的显着改善证明了这一点。
{"title":"Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women?","authors":"Halil Tosun, Emre Can Akınsal, Gökhan Sönmez, Numan Baydilli, Deniz Demirci","doi":"10.2147/TCRM.S478919","DOIUrl":"10.2147/TCRM.S478919","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the effectiveness and safety of high-intensity focused electromagnetic technology (HIFEM) used as a therapeutic approach in patients with stress and mixed urinary incontinence.</p><p><strong>Patients and methods: </strong>Thirty-five females suffering from stress and mixed urinary incontinence were included in the study. The electromagnetic chair (BTL EMSELLA<sup>®</sup>) was applied to the patient's pelvic area twice a week for 28 minutes, totaling 6 sessions. The patients' \"International Consultation on Incontinence Questionnaire-Short Form\" (ICIQ-SF) scores and the number of daily absorbent pad usage were recorded. Results were evaluated after the sixth session and at a first-month follow-up.</p><p><strong>Results: </strong>The average ICIQ-SF score at baseline was 10.18 ± 4.19 (ranging from 2-18) which declined to 5.33 ± 3.97 after six sessions, and further improved to 4.26 ± 3.94 points at the one-month follow-up. After six sessions, an average improvement of 52.06% in ICIQ-SF score was observed, and after one month of follow-up, an average improvement of 59.6% was detected, which was found to be statistically significant (p=0.038). In addition, the mean number of pads used per day decreased to 1.25 ± 1.54 after treatment, a significant improvement was observed, and the mean daily pad use decreased further to 0.91 ± 1.11 at the first-month follow-up.</p><p><strong>Conclusion: </strong>HIFEM has demonstrated in our study its ability to safely and effectively treat female patients suffering from stress and mixed urinary incontinence, as evidenced by significant improvements in symptoms and quality of life observed in clinical trials.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"811-816"},"PeriodicalIF":2.8,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11619107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142787173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients. 不同剂量方案沙利度胺治疗中重度β-地中海贫血患者的疗效和安全性比较
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-11-29 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S481128
Wei-Jia Yang, Lian-Dong Shi, Ye Liang, Li-Ming Liang, Hao Zhang, Li Wang, Qian Zhou

Objective: In this study, we evaluated the effectiveness and safety of thalidomide by clinically observing 48 individuals with β-thalassemia who have been administered thalidomide in small and medium doses over a period of two years.

Methods: Thalidomide's efficacy was gauged by tracking hemoglobin (Hb) level alterations post its administration. Liver and kidney function impact was measured through tests for alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, and creatinine. Hemolysis effects were assessed via total bilirubin and indirect bilirubin level measurements. Thrombosis detection was performed using ultrasound examinations of deep vein vessels in the upper and lower extremities. Any adverse effects of thalidomide were recorded during the observation period. Lower dose thalidomide effectiveness was evaluated by monitoring Hb level changes following dosage reduction.

Results: The overall response rate (ORR) among the 48 participants was 91.7% (44 out of 48), with the main reaction (MaR) reaching 72.9% (35 out of 48). Hepatorenal toxicity was not monitored during the 2-year observation period, and there was no improvement in hemolysis. Most adverse effects were mild, with no instances of venous thrombosis and no cases of grade 2 or higher neurotoxicity. When the observation group was divided into three age categories (12-14 years old, 14-18 years old, and over 18 years old), there were no statistically significant differences in the occurrence of adverse reactions among the three groups. As there were some adverse reactions in ten cases, the treatment dose was reduced for them. The maintenance efficacy rate at one year of observation was 90% (9 out of 10).

Conclusion: This study confirmed that thalidomide in small doses over a 2-year observation period is effective, and has no instances of grade 2 or higher neurotoxicity. Long-term maintenance with small doses is recommended for enhanced safety.

目的:在这项研究中,我们通过临床观察48例β-地中海贫血患者,他们在两年的时间里服用了小剂量和中剂量的沙利度胺,来评估沙利度胺的有效性和安全性。方法:通过监测沙利度胺给药后血红蛋白(Hb)水平变化来评价沙利度胺的疗效。通过检测丙氨酸转氨酶、天冬氨酸转氨酶、血尿素氮和肌酐来测量肝肾功能的影响。通过总胆红素和间接胆红素水平测量来评估溶血效果。采用超声检查上、下肢深静脉血管,检测血栓形成。观察期间记录沙利度胺的不良反应。通过监测减少剂量后Hb水平的变化来评估低剂量沙利度胺的有效性。结果:48例患者的总有效率(ORR)为91.7%(44 / 48),主要反应(MaR)为72.9%(35 / 48)。2年观察期间未监测肝肾毒性,溶血情况无改善。大多数不良反应是轻微的,没有静脉血栓形成的情况下,没有2级或更高的神经毒性的情况下。将观察组分为12-14岁、14-18岁、18岁以上三个年龄段,三组不良反应发生率比较,差异均无统计学意义。其中10例出现不良反应,减量治疗。观察1年时维持有效率为90%(9 / 10)。结论:本研究证实,在2年的观察期内,小剂量的沙利度胺是有效的,没有2级或更高级别的神经毒性。建议小剂量长期维持以提高安全性。
{"title":"Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients.","authors":"Wei-Jia Yang, Lian-Dong Shi, Ye Liang, Li-Ming Liang, Hao Zhang, Li Wang, Qian Zhou","doi":"10.2147/TCRM.S481128","DOIUrl":"10.2147/TCRM.S481128","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we evaluated the effectiveness and safety of thalidomide by clinically observing 48 individuals with β-thalassemia who have been administered thalidomide in small and medium doses over a period of two years.</p><p><strong>Methods: </strong>Thalidomide's efficacy was gauged by tracking hemoglobin (Hb) level alterations post its administration. Liver and kidney function impact was measured through tests for alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, and creatinine. Hemolysis effects were assessed via total bilirubin and indirect bilirubin level measurements. Thrombosis detection was performed using ultrasound examinations of deep vein vessels in the upper and lower extremities. Any adverse effects of thalidomide were recorded during the observation period. Lower dose thalidomide effectiveness was evaluated by monitoring Hb level changes following dosage reduction.</p><p><strong>Results: </strong>The overall response rate (ORR) among the 48 participants was 91.7% (44 out of 48), with the main reaction (MaR) reaching 72.9% (35 out of 48). Hepatorenal toxicity was not monitored during the 2-year observation period, and there was no improvement in hemolysis. Most adverse effects were mild, with no instances of venous thrombosis and no cases of grade 2 or higher neurotoxicity. When the observation group was divided into three age categories (12-14 years old, 14-18 years old, and over 18 years old), there were no statistically significant differences in the occurrence of adverse reactions among the three groups. As there were some adverse reactions in ten cases, the treatment dose was reduced for them. The maintenance efficacy rate at one year of observation was 90% (9 out of 10).</p><p><strong>Conclusion: </strong>This study confirmed that thalidomide in small doses over a 2-year observation period is effective, and has no instances of grade 2 or higher neurotoxicity. Long-term maintenance with small doses is recommended for enhanced safety.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"799-809"},"PeriodicalIF":2.8,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11616116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introducing Angle B: A Novel Quantitative Approach for Sagittal Alignment Reduction in Atlanto-Axial Dislocation Surgery. 介绍角度B:寰枢脱位手术中矢状位对准复位的一种新的定量方法。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-11-26 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S483075
Shengyu Cui, Xinyu Wang, Kang Li, Hailong Feng, Zhenlei Liu, Fengzeng Jian, Kai Wang

Objective: This study aims to establish a quantitative relationship between cervical lordosis (CL) and the rotation angle of the axis for the surgical reduction of atlantoaxial dislocation (AAD) and to explore the potential applications of this relationship in preoperative planning and selection of surgical techniques.

Methods: To construct the correlation between horizontal gaze and location of axis, we introduced the angle B, defined as the angle between the Frankfort horizontal line and the extension line of the posterior edge of the axis, and explored its application in surgical planning. We retrospectively analyzed imaging data from computed tomography of 23 AAD patients who had undergone posterior reduction and fixation. Theoretical equations were deduced through a series of angular transformations, and linear regression analysis was used to validate our findings.

Results: Our results showed a strong linear relationship between the change in CL (ΔCL) and the change in B(ΔB) (y=-1.0402x, coefficient of determination R²=0.978, P<0.001), supporting our deduction that ΔCL=ΔB. Furthermore, we found that the rotation angle of the axis (angle D) was equal to ΔCL. By resolving the atlantoaxial interval into the vertical dimension (h) and horizontal dimension (d), we could calculate the maximum vertical and horizontal distance that the axis could move theoretically according to a patient's maximum ΔCL. This finding supports our theory that the introduction of angle B can provide more precise preoperative planning and surgical technique selection for patients with AAD.

Conclusion: By introducing angle B and deducing the equation ΔB=ΔCL=D, we have provided an innovative tool for preoperative planning and surgical technique selection for patients with AAD. This equation not only helps surgeons achieve more precise and effective surgical reductions but also emphasizes the important role of angle B in surgical planning.

目的:本研究旨在建立寰枢脱位(atlantoaxial脱位,AAD)复位手术中颈椎前凸(CL)与椎轴旋转角度之间的定量关系,并探讨该关系在术前规划和手术技术选择中的潜在应用价值。方法:为了构建水平凝视与轴线位置之间的相关性,我们引入角度B,定义为法兰克福水平线与轴线后缘延线之间的角度,并探讨其在手术规划中的应用。我们回顾性分析了23例接受后路复位和固定的AAD患者的计算机断层成像资料。通过一系列的角度变换推导出理论方程,并用线性回归分析验证了我们的发现。结果:我们的研究结果显示CL (ΔCL)的变化与B(ΔB)的变化具有较强的线性关系(y=-1.0402x,决定系数R²=0.978,p)。结论:通过引入角度B,推导方程ΔB=ΔCL=D,为AAD患者的术前规划和手术技术选择提供了一种创新的工具。这个方程不仅可以帮助外科医生获得更精确有效的手术复位,也强调了B角在手术计划中的重要作用。
{"title":"Introducing Angle B: A Novel Quantitative Approach for Sagittal Alignment Reduction in Atlanto-Axial Dislocation Surgery.","authors":"Shengyu Cui, Xinyu Wang, Kang Li, Hailong Feng, Zhenlei Liu, Fengzeng Jian, Kai Wang","doi":"10.2147/TCRM.S483075","DOIUrl":"https://doi.org/10.2147/TCRM.S483075","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to establish a quantitative relationship between cervical lordosis (CL) and the rotation angle of the axis for the surgical reduction of atlantoaxial dislocation (AAD) and to explore the potential applications of this relationship in preoperative planning and selection of surgical techniques.</p><p><strong>Methods: </strong>To construct the correlation between horizontal gaze and location of axis, we introduced the angle B, defined as the angle between the Frankfort horizontal line and the extension line of the posterior edge of the axis, and explored its application in surgical planning. We retrospectively analyzed imaging data from computed tomography of 23 AAD patients who had undergone posterior reduction and fixation. Theoretical equations were deduced through a series of angular transformations, and linear regression analysis was used to validate our findings.</p><p><strong>Results: </strong>Our results showed a strong linear relationship between the change in CL (ΔCL) and the change in B(ΔB) (y=-1.0402x, coefficient of determination R²=0.978, P<0.001), supporting our deduction that ΔCL=ΔB. Furthermore, we found that the rotation angle of the axis (angle D) was equal to ΔCL. By resolving the atlantoaxial interval into the vertical dimension (h) and horizontal dimension (d), we could calculate the maximum vertical and horizontal distance that the axis could move theoretically according to a patient's maximum ΔCL. This finding supports our theory that the introduction of angle B can provide more precise preoperative planning and surgical technique selection for patients with AAD.</p><p><strong>Conclusion: </strong>By introducing angle B and deducing the equation ΔB=ΔCL=D, we have provided an innovative tool for preoperative planning and surgical technique selection for patients with AAD. This equation not only helps surgeons achieve more precise and effective surgical reductions but also emphasizes the important role of angle B in surgical planning.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"789-797"},"PeriodicalIF":2.8,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11607998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142772682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haemodynamic Changes in Adult Patients Transported in Emergency Medical Helicopters. A Systematic Review. 紧急医疗直升机运送的成人患者的血流动力学变化。系统回顾。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-11-23 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S488502
Alejandro Artero-García, Juan Gómez-Salgado, Francisco Javier Fernández-Carrasco, Juana María Vázquez-Lara, Juan Jesús García-Iglesias, Beatriz Mérida-Yáñez, Francisco Javier Muñoz-Vela, Luciano Rodríguez-Díaz

Objective: Patients transported by Helicopter Emergency Medical Services (HEMS) suffer a series of haemodynamic changes, mainly in terms of blood pressure, heart rate, and oxygen saturation, which worsen at different stages of the flight. The aim of this study was to identify haemodynamic changes in adult patients transported by the Helicopter Emergency Medical Service.

Methods: A systematic review of studies published between January 2013 to April 2023 was conducted following the PRISMA 2020 guidelines criteria in the Pubmed, Scopus and Web of Science electronic databases. Methodological quality was assessed using the critical appraisal tool for non-randomised studies of the Joanna Briggs Institute (JBI). The followed protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO) with code CRD4202222355798. Two independent reviewers read and extracted the information of the studies.

Results: Eight studies were included in the review, which showed significant haemodynamic changes during transport by HEMS. All studies recorded readings at three points of the mission: pre-flight, in-flight, and post-flight. The greatest change in physiological variables is visible in oxygen saturation, during the in-flight phase, with a decrease in this value. Blood pressure mainly increased in various phases of the mission, especially in the in-flight phase. Heart rate also changed across the mission phases, mainly in the pre-flight and post-flight phases, increasing and decreasing during the flight.

Conclusion: Patients transported by helicopter undergo haemodynamic changes during the different stages of evacuation (pre-flight, in-flight, and post-flight). However, there is a need for further studies on helicopter transport of patients due to the paucity of publications on this topic.

目的:直升机紧急医疗服务(HEMS)运送的病人会出现一系列血流动力学变化,主要表现在血压、心率和血氧饱和度方面,这些变化在飞行的不同阶段会加剧。本研究旨在确定由直升机紧急医疗服务运送的成年患者的血流动力学变化:按照 PRISMA 2020 指南标准,在 Pubmed、Scopus 和 Web of Science 电子数据库中对 2013 年 1 月至 2023 年 4 月间发表的研究进行了系统性回顾。采用乔安娜-布里格斯研究所(JBI)的非随机研究关键评估工具对方法学质量进行了评估。所遵循的方案已在国际系统综述前瞻性注册中心(PROSPERO)注册,代码为 CRD4202222355798。两位独立审稿人阅读并提取了研究信息:共有八项研究被纳入综述,这些研究显示,在使用急救车运送病人的过程中,血流动力学发生了显著变化。所有研究都记录了飞行任务中三个时间点的读数:飞行前、飞行中和飞行后。生理变量中变化最大的是飞行中阶段的血氧饱和度,该值有所下降。血压主要在飞行任务的各个阶段上升,尤其是在飞行中阶段。心率也在飞行任务的各个阶段发生变化,主要是在飞行前和飞行后阶段,在飞行过程中有所上升和下降:结论:直升机运送的病人在撤离的不同阶段(飞行前、飞行中和飞行后)都会发生血流动力学变化。然而,由于相关出版物较少,还需要对直升机运送病人进行进一步研究。
{"title":"Haemodynamic Changes in Adult Patients Transported in Emergency Medical Helicopters. A Systematic Review.","authors":"Alejandro Artero-García, Juan Gómez-Salgado, Francisco Javier Fernández-Carrasco, Juana María Vázquez-Lara, Juan Jesús García-Iglesias, Beatriz Mérida-Yáñez, Francisco Javier Muñoz-Vela, Luciano Rodríguez-Díaz","doi":"10.2147/TCRM.S488502","DOIUrl":"10.2147/TCRM.S488502","url":null,"abstract":"<p><strong>Objective: </strong>Patients transported by Helicopter Emergency Medical Services (HEMS) suffer a series of haemodynamic changes, mainly in terms of blood pressure, heart rate, and oxygen saturation, which worsen at different stages of the flight. The aim of this study was to identify haemodynamic changes in adult patients transported by the Helicopter Emergency Medical Service.</p><p><strong>Methods: </strong>A systematic review of studies published between January 2013 to April 2023 was conducted following the PRISMA 2020 guidelines criteria in the Pubmed, Scopus and Web of Science electronic databases. Methodological quality was assessed using the critical appraisal tool for non-randomised studies of the Joanna Briggs Institute (JBI). The followed protocol has been registered in the International Prospective Register of Systematic Reviews (PROSPERO) with code CRD4202222355798. Two independent reviewers read and extracted the information of the studies.</p><p><strong>Results: </strong>Eight studies were included in the review, which showed significant haemodynamic changes during transport by HEMS. All studies recorded readings at three points of the mission: pre-flight, in-flight, and post-flight. The greatest change in physiological variables is visible in oxygen saturation, during the in-flight phase, with a decrease in this value. Blood pressure mainly increased in various phases of the mission, especially in the in-flight phase. Heart rate also changed across the mission phases, mainly in the pre-flight and post-flight phases, increasing and decreasing during the flight.</p><p><strong>Conclusion: </strong>Patients transported by helicopter undergo haemodynamic changes during the different stages of evacuation (pre-flight, in-flight, and post-flight). However, there is a need for further studies on helicopter transport of patients due to the paucity of publications on this topic.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"775-787"},"PeriodicalIF":2.8,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11600915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leveraging 3D Convolutional Neural Networks for Accurate Recognition and Localization of Ankle Fractures. 利用三维卷积神经网络准确识别和定位踝关节骨折。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-11-20 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S483907
Hua Wang, Jichong Ying, Jianlei Liu, Tianming Yu, Dichao Huang

Background: Ankle fractures are common injuries with substantial implications for patient mobility and quality of life. Traditional imaging methods, while standard, have limitations in detecting subtle fractures and distinguishing them from complex bone structures. The advent of 3D Convolutional Neural Networks (3D-CNNs) offers a promising avenue for enhancing the accuracy and reliability of ankle fracture diagnoses.

Methods: In this study, we acquired 1453 high-resolution CT scans and processed them through three distinct 3D-CNN models: 3D-Mobilenet, 3D-Resnet101, and 3D-EfficientNetB7. Our approach involved meticulous preprocessing of images, including normalization and resampling, followed by a systematic comparative evaluation of the models based on accuracy, Area Under the Curve (AUC), and recall metrics. Additionally, the integration of Gradient-weighted Class Activation Mapping (Grad-CAM) provided visual interpretability of the models' predictive focus points.

Results: The 3D-EfficientNetB7 model outperformed the other models, achieving an accuracy of 0.91 and an AUC of 0.94 after 20 training epochs. It demonstrated particularly effective in the accurate detection and localization of subtle and complex fractures. Grad-CAM visualizations confirmed the model's focus on clinically relevant areas, aligning with expert assessments and enhancing trust in automated diagnostics. Spatial localization techniques were pivotal in improving interpretability, offering clear visual guidance for pinpointing fracture sites.

Conclusion: Our findings highlight the effectiveness of the 3D-EfficientNetB7 model in diagnosing ankle fractures, supported by robust performance metrics and enhanced visualization tools.

背景:踝关节骨折是一种常见损伤,对患者的活动能力和生活质量有很大影响。传统的成像方法虽然标准,但在检测细微骨折并将其与复杂的骨结构区分开来方面存在局限性。三维卷积神经网络(3D-CNNs)的出现为提高踝关节骨折诊断的准确性和可靠性提供了一个前景广阔的途径:在这项研究中,我们获取了 1453 张高分辨率 CT 扫描图像,并通过三种不同的 3D-CNN 模型对其进行了处理:3D-Mobilenet、3D-Resnet101 和 3D-EfficientNetB7 。我们的方法包括对图像进行细致的预处理,包括归一化和重采样,然后根据准确度、曲线下面积(AUC)和召回指标对模型进行系统的比较评估。此外,梯度加权类激活映射(Grad-CAM)的整合为模型的预测焦点提供了可视化解释:结果:3D-EfficientNetB7 模型的表现优于其他模型,经过 20 次训练后,准确率达到 0.91,AUC 达到 0.94。该模型在准确检测和定位细微复杂骨折方面表现尤为突出。Grad-CAM 可视化证实了该模型对临床相关区域的关注,与专家的评估结果一致,增强了对自动诊断的信任。空间定位技术在提高可解释性方面发挥了关键作用,为精确定位骨折部位提供了清晰的视觉指导:我们的研究结果凸显了 3D-EfficientNetB7 模型在诊断踝关节骨折方面的有效性,并得到了强大的性能指标和增强型可视化工具的支持。
{"title":"Leveraging 3D Convolutional Neural Networks for Accurate Recognition and Localization of Ankle Fractures.","authors":"Hua Wang, Jichong Ying, Jianlei Liu, Tianming Yu, Dichao Huang","doi":"10.2147/TCRM.S483907","DOIUrl":"10.2147/TCRM.S483907","url":null,"abstract":"<p><strong>Background: </strong>Ankle fractures are common injuries with substantial implications for patient mobility and quality of life. Traditional imaging methods, while standard, have limitations in detecting subtle fractures and distinguishing them from complex bone structures. The advent of 3D Convolutional Neural Networks (3D-CNNs) offers a promising avenue for enhancing the accuracy and reliability of ankle fracture diagnoses.</p><p><strong>Methods: </strong>In this study, we acquired 1453 high-resolution CT scans and processed them through three distinct 3D-CNN models: 3D-Mobilenet, 3D-Resnet101, and 3D-EfficientNetB7. Our approach involved meticulous preprocessing of images, including normalization and resampling, followed by a systematic comparative evaluation of the models based on accuracy, Area Under the Curve (AUC), and recall metrics. Additionally, the integration of Gradient-weighted Class Activation Mapping (Grad-CAM) provided visual interpretability of the models' predictive focus points.</p><p><strong>Results: </strong>The 3D-EfficientNetB7 model outperformed the other models, achieving an accuracy of 0.91 and an AUC of 0.94 after 20 training epochs. It demonstrated particularly effective in the accurate detection and localization of subtle and complex fractures. Grad-CAM visualizations confirmed the model's focus on clinically relevant areas, aligning with expert assessments and enhancing trust in automated diagnostics. Spatial localization techniques were pivotal in improving interpretability, offering clear visual guidance for pinpointing fracture sites.</p><p><strong>Conclusion: </strong>Our findings highlight the effectiveness of the 3D-EfficientNetB7 model in diagnosing ankle fractures, supported by robust performance metrics and enhanced visualization tools.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"761-773"},"PeriodicalIF":2.8,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11585985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Permissive Hypercapnia on Postoperative Early Plasma Neurofilament Light Chain in Elderly Patients Undergoing Laparoscopic Surgery: A Prospective, Randomized Controlled Trial. 允许性高碳酸血症对腹腔镜手术老年患者术后早期血浆神经丝轻链的影响:一项前瞻性随机对照试验。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S492456
Ya-Zhi Xi, Xue-Lian Wei, Lei Xie, Xiao-Yu Jia, Zhen-Ping Li, Qing-He Zhou

Background: The effects of intraoperative permissive hypercapnia (PaCO2 of 45-55 mmHg) on the central nervous system remain unclear. Neurofilament light chain (NfL, a protein found in the axons and nerve fibers of neurons) has been associated with central nervous system disorders. This study investigated the effect of intraoperative permissive hypercapnia on plasma NfL concentration 1 day postoperatively, and in turn on the central nervous system, during laparoscopic surgery.

Methods: This investigation was a prospective, single-blind randomized controlled trial. Eighty-four individuals aged above 60 years were randomly allocated to either the normocapnia group with an PaCO2 of 35-45 mmHg (n=42) or the hypercapnia group with a PaCO2 of 45-55 mmHg (n=42). The primary outcome was the 1-day postoperative plasma NfL concentration. Secondary outcomes included the area under the curve (AUC) values for PaCO2 and regional cerebral oxygen saturation (rSO2). The Mann-Whitney U-test was mainly used to analyze the outcomes.

Results: The final analysis included 38 and 40 patients in the normocapnia and hypercapnia groups, respectively. There was no statistically significant difference observed between the groups regarding the preoperative and 1-day postoperative plasma NfL concentration (14.0 [11.1, 19.9] vs 16.3 [9.06, 19.9] pg/mL, P>0.05; 23.4 [16.8, 32.3] vs 21.5 [15.6, 29.9] pg/mL, P>0.05, respectively). However, in both groups, the postoperative plasma concentration of NfL showed a significant increase when compared with the preoperative levels (both P < 0.001). The AUCs of PaCO2 and rSO2 from the beginning to the end of the pneumoperitoneum were significantly higher in the hypercapnia group compared with the normocapnia group (both P<0.05).

Conclusion: Our results indicate that intraoperative permissive hypercapnia targeting a PaCO2 of 45-55 mmHg does not significantly influence postoperative early plasma NfL elevation levels in elderly patients undergoing laparoscopic surgery. During general anesthesia, intraoperative permissive hypercapnia might not significantly impact the central nervous system.

背景:术中允许性高碳酸血症(PaCO2 为 45-55 mmHg)对中枢神经系统的影响仍不清楚。神经丝蛋白轻链(NfL,一种存在于神经元轴突和神经纤维中的蛋白质)与中枢神经系统疾病有关。本研究调查了腹腔镜手术过程中,术中允许性高碳酸血症对术后1天血浆NfL浓度的影响,以及对中枢神经系统的影响:该研究是一项前瞻性、单盲随机对照试验。84 名 60 岁以上的患者被随机分配到 PaCO2 为 35-45 mmHg 的正常碳酸血症组(42 人)或 PaCO2 为 45-55 mmHg 的高碳酸血症组(42 人)。主要结果是术后 1 天的血浆 NfL 浓度。次要结果包括 PaCO2 和区域脑氧饱和度(rSO2)的曲线下面积(AUC)值。结果主要采用曼-惠特尼U检验进行分析:最终分析结果显示,正常碳酸血症组和高碳酸血症组分别有 38 名和 40 名患者。两组患者术前和术后 1 天血浆 NfL 浓度差异无统计学意义(分别为 14.0 [11.1, 19.9] vs 16.3 [9.06, 19.9] pg/mL,P>0.05;23.4 [16.8, 32.3] vs 21.5 [15.6, 29.9] pg/mL,P>0.05)。然而,与术前水平相比,两组患者术后血浆中的 NfL 浓度均有显著增加(均 P <0.001)。与正常碳酸血症组相比,高碳酸血症组从腹腔积气开始到结束的 PaCO2 和 rSO2 的 AUCs 均明显升高(均为 P0.05):我们的研究结果表明,术中允许PaCO2为45-55 mmHg的高碳酸血症不会明显影响接受腹腔镜手术的老年患者术后早期血浆NfL升高水平。在全身麻醉过程中,术中允许性高碳酸血症可能不会对中枢神经系统产生明显影响。
{"title":"Impact of Permissive Hypercapnia on Postoperative Early Plasma Neurofilament Light Chain in Elderly Patients Undergoing Laparoscopic Surgery: A Prospective, Randomized Controlled Trial.","authors":"Ya-Zhi Xi, Xue-Lian Wei, Lei Xie, Xiao-Yu Jia, Zhen-Ping Li, Qing-He Zhou","doi":"10.2147/TCRM.S492456","DOIUrl":"10.2147/TCRM.S492456","url":null,"abstract":"<p><strong>Background: </strong>The effects of intraoperative permissive hypercapnia (<i>P</i>aCO<sub>2</sub> of 45-55 mmHg) on the central nervous system remain unclear. Neurofilament light chain (NfL, a protein found in the axons and nerve fibers of neurons) has been associated with central nervous system disorders. This study investigated the effect of intraoperative permissive hypercapnia on plasma NfL concentration 1 day postoperatively, and in turn on the central nervous system, during laparoscopic surgery.</p><p><strong>Methods: </strong>This investigation was a prospective, single-blind randomized controlled trial. Eighty-four individuals aged above 60 years were randomly allocated to either the normocapnia group with an <i>P</i>aCO<sub>2</sub> of 35-45 mmHg (n=42) or the hypercapnia group with a <i>P</i>aCO<sub>2</sub> of 45-55 mmHg (n=42). The primary outcome was the 1-day postoperative plasma NfL concentration. Secondary outcomes included the area under the curve (AUC) values for <i>P</i>aCO<sub>2</sub> and regional cerebral oxygen saturation (rSO<sub>2</sub>). The Mann-Whitney <i>U</i>-test was mainly used to analyze the outcomes.</p><p><strong>Results: </strong>The final analysis included 38 and 40 patients in the normocapnia and hypercapnia groups, respectively. There was no statistically significant difference observed between the groups regarding the preoperative and 1-day postoperative plasma NfL concentration (14.0 [11.1, 19.9] vs 16.3 [9.06, 19.9] pg/mL, <i>P</i>>0.05; 23.4 [16.8, 32.3] vs 21.5 [15.6, 29.9] pg/mL, <i>P</i>>0.05, respectively). However, in both groups, the postoperative plasma concentration of NfL showed a significant increase when compared with the preoperative levels (both <i>P</i> < 0.001). The AUCs of <i>P</i>aCO<sub>2</sub> and rSO<sub>2</sub> from the beginning to the end of the pneumoperitoneum were significantly higher in the hypercapnia group compared with the normocapnia group (both <i>P<</i>0.05).</p><p><strong>Conclusion: </strong>Our results indicate that intraoperative permissive hypercapnia targeting a <i>P</i>aCO<sub>2</sub> of 45-55 mmHg does not significantly influence postoperative early plasma NfL elevation levels in elderly patients undergoing laparoscopic surgery. During general anesthesia, intraoperative permissive hypercapnia might not significantly impact the central nervous system.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"749-759"},"PeriodicalIF":2.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medications Associated with Geriatric Syndromes and Prescribing Patterns: The Impact of Excessive Polypharmacy in Older Adult Patients. 与老年综合症相关的药物和处方模式:老年患者过度使用多种药物的影响》。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S493095
Ahmad Al-Azayzih, Walid Al-Qerem, Sayer Al-Azzam, Karem H Alzoubi, Feras Jirjees, Khalid Al-Kubaisi, Zelal Kharaba, Suhaib Muflih, Roaa J Kanaan, Ayah H Abandeh

Aims of the study: To assess the prescribing patterns of medications associated with geriatric syndromes (MAGS) in older adult patients with multiple comorbidities and to identify factors that may increase the risk of MAGS prescribing in the same population.

Methodology: This study involved a retrospective analysis of the electronic medical records of older adult patients (≥ 65 years) who visited outpatient clinics at King Abdullah University Hospital (KAUH) in Jordan between January 1, 2019, and June 1, 2024. The collected data included patient demographics, medical history, and medications, focusing on those associated with geriatric syndromes. Descriptive and logistic regression statistical analyses were performed using SPSS with the significance level set at p < 0.05.

Results: The study included 1087 older adult patients (52.7% female), with a median age of 71 years. The common conditions existed were peptic ulcer disease (57.1%), hypertension (54.65%), and uncomplicated diabetes (50%). Polypharmacy was presented in 94.8% of total patients number, with 41.6% experiencing excessive polypharmacy. Antihypertensives (78.4%), non-opioid analgesics (56.5%), and antidiabetics (51.8%) were the most frequently prescribed MAGS, which frequently resulted in falls (96%), urinary incontinence (87.6%), and depression (87.3%). Patients with excessive polypharmacy had significantly higher MAGS scores than those with moderate or mild polypharmacy (95% CI: -2.230 to -1.770 and -3.322 to -2.678, respectively, P < 0.001).

Conclusion: The findings demonstrate a high prevalence of excessive polypharmacy among older adult patients, significantly contributing to the elevated prescription level of medications associated with geriatric syndrome occurrence, particularly falls, urinary incontinence, and depression.

研究目的评估患有多种并发症的老年患者开具老年综合征(MAGS)相关药物处方的模式,并确定可能增加同一人群开具MAGS处方风险的因素:本研究对2019年1月1日至2024年6月1日期间在约旦阿卜杜拉国王大学医院(KAUH)门诊就诊的老年患者(≥65岁)的电子病历进行了回顾性分析。收集的数据包括患者的人口统计学特征、病史和用药情况,重点是与老年综合征相关的药物。使用 SPSS 进行了描述性和逻辑回归统计分析,显著性水平设定为 p <0.05:研究包括 1087 名老年患者(52.7% 为女性),中位年龄为 71 岁。常见疾病为消化性溃疡(57.1%)、高血压(54.65%)和无并发症糖尿病(50%)。在所有患者中,94.8%的人使用多种药物,41.6%的人使用过量多种药物。抗高血压药(78.4%)、非阿片类镇痛药(56.5%)和抗糖尿病药(51.8%)是最常处方的 MAGS,这些药物经常导致跌倒(96%)、尿失禁(87.6%)和抑郁(87.3%)。过度使用多种药物的患者的 MAGS 评分明显高于中度或轻度使用多种药物的患者(95% CI:分别为-2.230 至 -1.770 和-3.322 至 -2.678,P < 0.001):研究结果表明,在老年患者中,过度使用多种药物的情况非常普遍,这在很大程度上导致了与老年综合症(尤其是跌倒、尿失禁和抑郁)发生相关的药物处方水平升高。
{"title":"Medications Associated with Geriatric Syndromes and Prescribing Patterns: The Impact of Excessive Polypharmacy in Older Adult Patients.","authors":"Ahmad Al-Azayzih, Walid Al-Qerem, Sayer Al-Azzam, Karem H Alzoubi, Feras Jirjees, Khalid Al-Kubaisi, Zelal Kharaba, Suhaib Muflih, Roaa J Kanaan, Ayah H Abandeh","doi":"10.2147/TCRM.S493095","DOIUrl":"10.2147/TCRM.S493095","url":null,"abstract":"<p><strong>Aims of the study: </strong>To assess the prescribing patterns of medications associated with geriatric syndromes (MAGS) in older adult patients with multiple comorbidities and to identify factors that may increase the risk of MAGS prescribing in the same population.</p><p><strong>Methodology: </strong>This study involved a retrospective analysis of the electronic medical records of older adult patients (≥ 65 years) who visited outpatient clinics at King Abdullah University Hospital (KAUH) in Jordan between January 1, 2019, and June 1, 2024. The collected data included patient demographics, medical history, and medications, focusing on those associated with geriatric syndromes. Descriptive and logistic regression statistical analyses were performed using SPSS with the significance level set at p < 0.05.</p><p><strong>Results: </strong>The study included 1087 older adult patients (52.7% female), with a median age of 71 years. The common conditions existed were peptic ulcer disease (57.1%), hypertension (54.65%), and uncomplicated diabetes (50%). Polypharmacy was presented in 94.8% of total patients number, with 41.6% experiencing excessive polypharmacy. Antihypertensives (78.4%), non-opioid analgesics (56.5%), and antidiabetics (51.8%) were the most frequently prescribed MAGS, which frequently resulted in falls (96%), urinary incontinence (87.6%), and depression (87.3%). Patients with excessive polypharmacy had significantly higher MAGS scores than those with moderate or mild polypharmacy (95% CI: -2.230 to -1.770 and -3.322 to -2.678, respectively, P < 0.001).</p><p><strong>Conclusion: </strong>The findings demonstrate a high prevalence of excessive polypharmacy among older adult patients, significantly contributing to the elevated prescription level of medications associated with geriatric syndrome occurrence, particularly falls, urinary incontinence, and depression.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"741-748"},"PeriodicalIF":2.8,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure. 治疗急性慢性肝衰竭的三种人工肝模型。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S485620
Yanping Xiang, Renhua Li, Jia Cai, Qian Jiang

Background: This study aimed to investigate clinical efficacy, safety and short-term prognosis of plasma exchange (PE), plasma perfusion combining PE (PP+PE), dual-plasma molecular adsorption system combining PE (DPMAS+PE) in treating acute-on-chronic liver failure (ACLF).

Methods: Two hundred and fourteen ACLF patients admitted to our hospital were included and divided into PE (n = 72), PP+PE (n = 75), DPMAS+PE group (n = 67). Laboratory indexes and MELD scores were collected, and clinical efficacy was compared. Patients' adverse reactions during and 24-h after treatment were collected, and safety was compared. Survival status of patients was followed-up within 90 days, and prognosis was analyzed.

Results: PE, PP+PE and DPMAS+PE significantly reduce TBiL, DBiL, ALT, AST, SA, PT, INR, PCT and CRP levels, and increase PA and PTA levels, compared with pre-treatments (P < 0.05). WBC and SCR levels in DPMAS+PE group decreased significantly post-treatment (P < 0.05). Na+ and Cl- levels in PE and PP+PE group decreased significantly post-treatment (P < 0.05). Total adverse reaction incidence in PE, PP+PE, DPMAS+PE group were 38.89%, 22.70%, 17.90%, respectively, with significant differences among three groups (P < 0.05). Ninety-day mortality rates of patients in PE, PP+PE, DPMAS+PE group were 41.67%, 34.67%, 20.90%, respectively, with significant differences among three groups (P < 0.05).

Conclusion: PE, PP+PE and DPMAS+PE three artificial liver treatment modes can effectively improve liver, kidney and coagulation function of ACLF patients. DPMAS+PE demonstrated better ability to remove endotoxin and inflammatory mediators, showed advantages in reducing ACLF patient mortality within 90 days, and had the least impact on electrolyte post-treatment. Therefore, DPMAS+PE can be used as a better choice for clinical treatment.

研究背景本研究旨在探讨血浆置换(PE)、血浆灌流联合PE(PP+PE)、双血浆分子吸附系统联合PE(DPMAS+PE)治疗急慢性肝衰竭(ACLF)的临床疗效、安全性和短期预后:方法:纳入本院收治的214例ACLF患者,分为PE组(72例)、PP+PE组(75例)和DPMAS+PE组(67例)。收集实验室指标和 MELD 评分,比较临床疗效。收集患者治疗期间和治疗后 24 小时的不良反应,比较安全性。对患者90天内的生存状况进行随访,分析预后情况:与治疗前相比,PE、PP+PE 和 DPMAS+PE 能明显降低 TBiL、DBiL、ALT、AST、SA、PT、INR、PCT 和 CRP 水平,提高 PA 和 PTA 水平(P < 0.05)。DPMAS+PE组的白细胞和SCR水平在治疗后明显下降(P < 0.05)。PE组和PP+PE组的Na+和Cl-水平在治疗后明显下降(P < 0.05)。PE组、PP+PE组、DPMAS+PE组不良反应总发生率分别为38.89%、22.70%、17.90%,三组间差异显著(P<0.05)。PE组、PP+PE组、DPMAS+PE组患者的90天死亡率分别为41.67%、34.67%、20.90%,三组间差异有学意义(P<0.05):结论:PE、PP+PE、DPMAS+PE三种人工肝治疗模式可有效改善ACLF患者的肝、肾及凝血功能。DPMAS+PE具有更好的清除内毒素和炎症介质的能力,在降低ACLF患者90天内死亡率方面表现出优势,且治疗后对电解质的影响最小。因此,DPMAS+PE 可作为临床治疗的更好选择。
{"title":"Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure.","authors":"Yanping Xiang, Renhua Li, Jia Cai, Qian Jiang","doi":"10.2147/TCRM.S485620","DOIUrl":"10.2147/TCRM.S485620","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate clinical efficacy, safety and short-term prognosis of plasma exchange (PE), plasma perfusion combining PE (PP+PE), dual-plasma molecular adsorption system combining PE (DPMAS+PE) in treating acute-on-chronic liver failure (ACLF).</p><p><strong>Methods: </strong>Two hundred and fourteen ACLF patients admitted to our hospital were included and divided into PE (n = 72), PP+PE (n = 75), DPMAS+PE group (n = 67). Laboratory indexes and MELD scores were collected, and clinical efficacy was compared. Patients' adverse reactions during and 24-h after treatment were collected, and safety was compared. Survival status of patients was followed-up within 90 days, and prognosis was analyzed.</p><p><strong>Results: </strong>PE, PP+PE and DPMAS+PE significantly reduce TBiL, DBiL, ALT, AST, SA, PT, INR, PCT and CRP levels, and increase PA and PTA levels, compared with pre-treatments (<i>P</i> < 0.05). WBC and SCR levels in DPMAS+PE group decreased significantly post-treatment (<i>P</i> < 0.05). Na<sup>+</sup> and Cl<sup>-</sup> levels in PE and PP+PE group decreased significantly post-treatment (<i>P</i> < 0.05). Total adverse reaction incidence in PE, PP+PE, DPMAS+PE group were 38.89%, 22.70%, 17.90%, respectively, with significant differences among three groups (<i>P</i> < 0.05). Ninety-day mortality rates of patients in PE, PP+PE, DPMAS+PE group were 41.67%, 34.67%, 20.90%, respectively, with significant differences among three groups (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>PE, PP+PE and DPMAS+PE three artificial liver treatment modes can effectively improve liver, kidney and coagulation function of ACLF patients. DPMAS+PE demonstrated better ability to remove endotoxin and inflammatory mediators, showed advantages in reducing ACLF patient mortality within 90 days, and had the least impact on electrolyte post-treatment. Therefore, DPMAS+PE can be used as a better choice for clinical treatment.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"731-740"},"PeriodicalIF":2.8,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142547611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of Speckle Tracking Echocardiographic Parameters in Predicting Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Non-Valvular Atrial Fibrillation. 斑点追踪超声心动图参数在预测非瓣膜性心房颤动患者导管消融后心房颤动复发中的实用性。
IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2024-10-05 eCollection Date: 2024-01-01 DOI: 10.2147/TCRM.S486056
Decai Zeng, Linyan Li, Shuai Chang, Xiaofeng Zhang, Yanfen Zhong, Yongzhi Cai, Tongtong Huang, Ji Wu

Background: Despite the efficacy of catheter ablation (CA) as a treatment for non-valvular atrial fibrillation (NVAF), many patients still experience atrial fibrillation (AF) recurrence after CA. This study aimed to evaluate the predictive value of speckle tracking echocardiographic (STE) parameters for AF recurrence post-ablation.

Methods: A total of 380 NVAF patients treated with CA at the First Affiliated Hospital of Guangxi Medical University from January 2020 to March 2023 were prospectively recruited. The mean age was 59.4 ± 10.8 years, and 72.1% were male, including 150 patients (39.5%) with persistent AF and 230 patients (60.5%) with paroxysmal AF. STE was used to evaluate baseline left atrial (LA) function before CA within 48h. Over a median follow-up of 9 (interquartile range, 4-17) months, AF recurrence occurred in 132 patients (34.7%).

Results: The recurrence group showed lower left ventricular ejection fraction, LA reservoir strain (LASr), and conduit strain (LAScd), but higher LA stiffness than non- recurrence group (all P < 0.05). Multivariable Cox regression identified LA stiffness and LASr as independent risk factors. Time-dependent ROC analysis showed that LA stiffness (AUC 0.768, 95% CI 0.705-0.831) and LASr (AUC 0.755, 95% CI 0.691-0.820) were better at predicting 1-year AF recurrence than other risk factors. For 2-year AF recurrence post-catheter ablation, LA stiffness (AUC 0.866, 95% CI 0.804-0.928) and LASr (AUC 0.860, 95% CI 0.800-0.920) also demonstrated superior predictive performance. Kaplan-Meier curves showed a significant difference in AF recurrence rate for patients with LA stiffness > 0.55 and LASr ≤ 24.3% (Log rank P < 0.01).

Conclusion: Evaluation of LA function using STE assists in stratifying the risk of AF recurrence in NVAF patients and guiding follow-up management. LASr and LA stiffness are independent predictors of AF recurrence following CA in NVAF patients, and potentially outperforming other morphological parameters.

背景:尽管导管消融术(CA)作为非瓣膜性心房颤动(NVAF)的治疗方法效果显著,但许多患者在消融术后仍会出现心房颤动(AF)复发。本研究旨在评估斑点追踪超声心动图(STE)参数对消融术后房颤复发的预测价值:方法:前瞻性招募了 380 名 2020 年 1 月至 2023 年 3 月在广西医科大学第一附属医院接受 CA 治疗的 NVAF 患者。平均年龄为(59.4±10.8)岁,72.1%为男性,包括150例(39.5%)持续性房颤患者和230例(60.5%)阵发性房颤患者。STE 用于评估 48 小时内 CA 前的左心房(LA)基线功能。在中位随访 9 个月(四分位间范围为 4-17 个月)期间,132 名患者(34.7%)出现房颤复发:复发组的左心室射血分数、LA储腔应变(LASr)和导管应变(LAScd)均低于非复发组,但LA僵硬度高于非复发组(P均<0.05)。多变量 Cox 回归确定 LA 硬度和 LASr 为独立风险因素。时间依赖性 ROC 分析显示,LA 僵硬度(AUC 0.768,95% CI 0.705-0.831)和 LASr(AUC 0.755,95% CI 0.691-0.820)在预测 1 年房颤复发方面优于其他风险因素。对于导管消融术后 2 年的房颤复发,LA 僵硬度(AUC 0.866,95% CI 0.804-0.928)和 LASr(AUC 0.860,95% CI 0.800-0.920)也显示出更优越的预测性能。Kaplan-Meier曲线显示,LA僵硬度>0.55和LASr≤24.3%的患者房颤复发率有显著差异(对数秩P<0.01):结论:使用 STE 评估 LA 功能有助于对 NVAF 患者房颤复发风险进行分层,并指导后续管理。LASr和LA僵硬度是预测NVAF患者CA术后房颤复发的独立指标,可能优于其他形态学参数。
{"title":"The Utility of Speckle Tracking Echocardiographic Parameters in Predicting Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Non-Valvular Atrial Fibrillation.","authors":"Decai Zeng, Linyan Li, Shuai Chang, Xiaofeng Zhang, Yanfen Zhong, Yongzhi Cai, Tongtong Huang, Ji Wu","doi":"10.2147/TCRM.S486056","DOIUrl":"10.2147/TCRM.S486056","url":null,"abstract":"<p><strong>Background: </strong>Despite the efficacy of catheter ablation (CA) as a treatment for non-valvular atrial fibrillation (NVAF), many patients still experience atrial fibrillation (AF) recurrence after CA. This study aimed to evaluate the predictive value of speckle tracking echocardiographic (STE) parameters for AF recurrence post-ablation.</p><p><strong>Methods: </strong>A total of 380 NVAF patients treated with CA at the First Affiliated Hospital of Guangxi Medical University from January 2020 to March 2023 were prospectively recruited. The mean age was 59.4 ± 10.8 years, and 72.1% were male, including 150 patients (39.5%) with persistent AF and 230 patients (60.5%) with paroxysmal AF. STE was used to evaluate baseline left atrial (LA) function before CA within 48h. Over a median follow-up of 9 (interquartile range, 4-17) months, AF recurrence occurred in 132 patients (34.7%).</p><p><strong>Results: </strong>The recurrence group showed lower left ventricular ejection fraction, LA reservoir strain (LASr), and conduit strain (LAScd), but higher LA stiffness than non- recurrence group (all <i>P</i> < 0.05). Multivariable Cox regression identified LA stiffness and LASr as independent risk factors. Time-dependent ROC analysis showed that LA stiffness (AUC 0.768, 95% CI 0.705-0.831) and LASr (AUC 0.755, 95% CI 0.691-0.820) were better at predicting 1-year AF recurrence than other risk factors. For 2-year AF recurrence post-catheter ablation, LA stiffness (AUC 0.866, 95% CI 0.804-0.928) and LASr (AUC 0.860, 95% CI 0.800-0.920) also demonstrated superior predictive performance. Kaplan-Meier curves showed a significant difference in AF recurrence rate for patients with LA stiffness > 0.55 and LASr ≤ 24.3% (Log rank <i>P</i> < 0.01).</p><p><strong>Conclusion: </strong>Evaluation of LA function using STE assists in stratifying the risk of AF recurrence in NVAF patients and guiding follow-up management. LASr and LA stiffness are independent predictors of AF recurrence following CA in NVAF patients, and potentially outperforming other morphological parameters.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"20 ","pages":"719-729"},"PeriodicalIF":2.8,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142393557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutics and Clinical Risk Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1